IFP Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $109K | Sell |
1,871
-6
| -0.3% | -$276 | ﹤0.01% | 1791 |
|
|
2025
Q4 | $84.1K | Sell |
1,877
-31
| -2% | -$1.3K | ﹤0.01% | 1908 |
|
|
2025
Q3 | $76.6K | Buy |
1,908
+43
| +2% | +$1.51K | ﹤0.01% | 1851 |
|
|
2025
Q2 | $61.5K | Sell |
1,865
-56
| -3% | -$1.83K | ﹤0.01% | 1937 |
|
|
2025
Q1 | $64.6K | Sell |
1,921
-37
| -2% | -$1.41K | ﹤0.01% | 1766 |
|
|
2024
Q4 | $76.9K | Sell |
1,958
-19
| -1% | -$786 | ﹤0.01% | 1602 |
|
|
2024
Q3 | $77.8K | Sell |
1,977
-125
| -6% | -$5.04K | ﹤0.01% | 1518 |
|
|
2024
Q2 | $82K | Sell |
2,102
-19
| -0.9% | -$759 | ﹤0.01% | 1445 |
|
|
2024
Q1 | $91.3K | Sell |
2,121
-27
| -1% | -$1.24K | ﹤0.01% | 1332 |
|
|
2023
Q4 | $98.9K | Sell |
2,148
-30
| -1% | -$1.06K | ﹤0.01% | 1248 |
|
|
2023
Q3 | $74.4K | Hold |
2,178
| – | – | ﹤0.01% | 1397 |
|
|
2023
Q2 | $83.8K | Buy |
2,178
+1,178
| +118% | +$46.8K | ﹤0.01% | 1395 |
|
|
2023
Q1 | $5.7K | Hold |
1,000
| – | – | ﹤0.01% | 2510 |
|
|
2022
Q4 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 3733 |
|
|
2022
Q3 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 3968 |
|
|
2022
Q2 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 3723 |
|
|
2022
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 3723 |
|
|
2021
Q4 | $31K | Hold |
1,000
| – | – | ﹤0.01% | 1757 |
|
|
2021
Q3 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 2120 |
|
|
2021
Q2 | $19K | Hold |
1,000
| – | – | ﹤0.01% | 1962 |
|
|
2021
Q1 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 1899 |
|
|
2020
Q4 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 1914 |
|
|
2020
Q3 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 1880 |
|
|
2020
Q2 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 1765 |
|
|
2020
Q1 | $11K | Buy |
+1,000
| New | +$14.2K | ﹤0.01% | 1741 |
|
Other funds holding XENE
ACA
DCM
PCH
